Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
XGX Pharma ApS
APS
Active
Reklamebeskyttelse
CVR 32289290
Frederiksgade 11, 1265
København K
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 16 years old
5 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
XGX Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
5M
9M
14M
18M
15M
2020
15M
2021
3M
2022
8M
2023
16M
2024
EBITDA
DKK millions
14M
10M
6M
2M
-3M
11M
2020
10M
-9%
2021
-2M
-120%
2022
3M
+250%
2023
9M
+200%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
15.226
14.515
2.918
8.101
16.034
Staff expenses
-4.004
-5.008
-4.420
-5.200
-7.263
EBITDA
11.221
9.507
-1.502
2.900
8.771
Depreciation & amort.
-355
-434
-788
-1.424
-2.234
EBIT
10.866
9.073
-2.290
1.476
6.537
Net financials
-2.662
-141
-391
-868
-916
Profit before tax
8.204
8.932
-2.681
624
5.673
Tax
-0
-0
-839
163
1.220
Net profit
6.004
7.249
-1.843
461
4.453
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
24.938
21.257
27.640
29.601
39.006
Equity
12.920
13.169
13.799
14.260
18.713
Long-term debt
1.857
1.365
7.649
5.873
3.953
Short-term debt
8.716
4.215
4.522
7.636
13.288
Total debt
10.573
5.580
12.171
13.509
17.241
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
54.7%
This company
2020
2024
Soliditetsgrad
48.0%
This company
38.2%
Market median
+26% vs market
2020
2024
Egenkapitalforrentning
23.8%
This company
18.4%
Market median
+29% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
27.8%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
0.41×
This company
2020
2024
Gæld/egenkapital
1.08×
This company
0.62×
Market median
-74% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on XGX Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
